The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg …
G Csemiczky, T Dieben, HJC Bennink, BM Landgren - Contraception, 1996 - Elsevier
During oral treatment with 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7
days, ovarian function, bleeding pattern and estradiol levels were evaluated. The study was
performed in a group-comparative, double-blind fashion. During a pre-treatment control
cycle, using ultrasound scan, follicular diameter was measured on cycle days 10–16 and
endometrial thickness on one of cycle days 22–26. Estradiol was measured at time of …
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7
days, ovarian function, bleeding pattern and estradiol levels were evaluated. The study was
performed in a group-comparative, double-blind fashion. During a pre-treatment control
cycle, using ultrasound scan, follicular diameter was measured on cycle days 10–16 and
endometrial thickness on one of cycle days 22–26. Estradiol was measured at time of …
以上显示的是最相近的搜索结果。 查看全部搜索结果